Zelda Therapeutics Ltd (ASX:ZLD) (OTCQB:ZLDAF) executive chairman Harry Karelis tells Proactive Investors the medical cannabis researcher's latest news. Initial results from a paediatric brain cancer study being conducted with the Telethon Kids Institute in Perth have validated that two chemicals naturally occurring...

Zelda Therapeutics Ltd (ASX:ZLD) executive chairman Harry Karelis updates Proactive Investors on the company’s global operations, following a January dual listing on the OTCQB Venture Market in the United States (OTCQB: ZLDAF). “We have a two-pronged strategy. One is the clinical trials where we know there is some...

Zelda Therapeutics' Dr Stewart Washer presents at Proactive's CEO Sessions

Dr Stewart Washer, executive director of Zelda Therapeutics Ltd (ASX:ZLD), discusses with Proactive the successful results from their recent observation autism trial in Chile. The results showed that in a group of 21 patients cannabis extracts were significantly more effective than conventional medicines used,...

Dr Stewart Washer, executive director for Zelda Therapeutics, speaks with Proactive Investors.